IJCRR - 6(10), May, 2014
Pages: 86-89
APOLIPOPROTEIN B / APOLIPOPROTEIN A1 RATIO: AN IMPROVED MARKER OF CARDIOVASCULAR RISK IN HYPOTHYROIDISM
Author: Priyanka G. Rakshasmare, P. N. Joshi
Category: Healthcare
[Download PDF]
Abstract:
Introduction: Hypothyroidism is a condition with decreased levels of thyroid hormones and elevated levels of Thyroid stimulating Hormone. Hypercholesterolemia is the characteristic feature of hypothyroidism and is also predisposing factor of atherosclerosis. Cholesterol in the body is transported through lipoproteins called Low density lipoprotein (LDL) and High density lipoprotein (HDL). The ratios, LDL/HDL and total cholesterol/HDL reflectthe direction of transport of cholesterol and are conventionally used to assess risk of cardiovascular diseases. ApolipoproteinB (apo B)present in Very low density lipoprotein(VLDL), Intermediate density lipoprotein (IDL), and LDL; is considered as atherogenicwhereas apolipoproteinA1 (apoA1) present in HDL, is antiatherogenic, anti-inflammatory with antioxidative properties. ApoB/apoA1 ratio represents the balance of proatherogenic and antiatherogenic lipoproteins. So the case control study was carried out to know the effectiveness of this improved ratio in hypothyroidism. Objective: To find out levels of total cholesterol (TC), LDL, HDL, apoB,andapo A1 2) To find out ratios- LDL/HDL, TC/HDL and apoB/apoA1 3) To check the effectiveness of apoB/apoA1 ratio as marker of cardiovascular risk in hypothyroidism. Methodology: Group A consists of 30 clinically diagnosed and biochemically confirmed cases of hypothyroidism. The levels of TC, HDL estimated using the kit, LDL using Friedewald formula, apoB and apoA1 byimmuno-turbidimetricmethod and result were compared with Group B (n=30) age and sex matched controls. Results: The levels of TC, LDL, and apoB were found to be increased highly significantly (p<0.001) and that of HDL and apoA1 decreased highly significantly (p<0.001). A highly significant increase in ratios namely LDL/HDL, TC /HDL and apoB/apoA1 was also observed. Conclusion: It can be concluded from the present study that apoB/apoA1 ratio is comparable with LDL/HDL and TC/HDL ratios. ApoB/apoA1 ratio can be an improved marker for prediction of cardiovascular risk in hypothyroidism.
Keywords: Hypothyroidism, hypercholesterolemia, apolipoprotein B/ apolipoproteinA1 ratio, cardiovascular risk.
Citation:
Priyanka G. Rakshasmare, P. N. Joshi. APOLIPOPROTEIN B / APOLIPOPROTEIN A1 RATIO: AN IMPROVED MARKER OF CARDIOVASCULAR RISK IN HYPOTHYROIDISM International Journal of Current Research and Review. 6(10), May, 86-89
References:
REFERENCES
1. Harper’s Illustrated Biochemistry, 29th Edition [Hypothyroidism-Page No. 145, 745, 746 Lipoproteins- Page No. 238-249,]
2. Teitz Textbook Clinical Chemistry And Molecular Diagnosis-4 th Edition- Lipids, Lipoproteins, Apolipoproteins, and other cardiovascular risk factors. [Page No. 942- 960] [Hypothyroidism-Page No.2057-2059]
3. Unnikrishnan AG, menon UV. Thyroid disorder in India: an epidemiological perspective. [Indian J Endocr metabolism 2011;15:78-81]
4. Evagelos N Liberopoulos, moses S Elisaf, dyslipidemia in patients with thyroid disorders. [Hormones 2002,1(4):218-223]
5. O’ Brien T, Dinneen SF, O’Brien PC, PalumboPJ. Hyperlipidemia in patients with primary and secondary hypothyroidism.[mayo Clinproc 1993;68:860- 6]
6. Cappola AR and Ladenson P W. Hypothyroidism and Atherosclerosis.[Journal of clinical Biochemistry and Metabolism 2003/ 88(6): 2438-2444]
7. Hueston WJ, Pearson WS, subclinical hypothyroidism and the risk of hypercholesterolemia.[Ann Fam Med 2004;2:351-5]
8. Marcovina S, Packard CJ, measurment and meaning of apolipoproteinA1 and apolipoprotein B plasma levels. [journal of internal med 2006;259:437-44]
9. Wallidus G and Junger I: The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy– a review of the evidence. [Journal of Internal Medicine 2006; 259: 493–519]
10. Wallidus G, Junger I. Rationale for using apolipoprotein B and apolipoprotein A-I as indicators of cardiac risk and as targets for lipid-lowering therapy.[ European Heart Journal. February 2005; 26(3): 210-212.]
11. Teitz Textbook Clinical Chemistry And Molecular Diagnosis-5 th Edition- measurment of apolipoproteins by immunoturbidimetric method [page No.785-88]
12. C.V Rizos, M.S Elisaf and E.N Liberopoulos Effects of Thyroid Dysfunction on Lipid Profile.[ Open Cardiovasc Med J.2011; 5: 76- 84]
|